ELEV

SEC Form 15-12G filed by Elevation Oncology Inc.

SEC Form EFFECT filed by Elevation Oncology Inc.

SEC Form EFFECT filed by Elevation Oncology Inc.

Amendment: SEC Form SCHEDULE 13D/A filed by Elevation Oncology Inc.

SEC Form 4 filed by Director Sandler Alan B.

SEC Form 4 filed by Director Mootz Darcy

SEC Form 4 filed by Director Elms Steve

SEC Form 4 filed by Director Clackson Timothy P

SEC Form 4 filed by Director Cherrington Julie M

SEC Form 4 filed by Director Carruthers R Michael

CHIEF FINANCIAL OFFICER Furlong Tammy closing all direct ownership in the company (SEC Form 4)

SEC Form S-8 POS filed by Elevation Oncology Inc.

SEC Form S-8 POS filed by Elevation Oncology Inc.

SEC Form S-8 POS filed by Elevation Oncology Inc.

SEC Form S-8 POS filed by Elevation Oncology Inc.

SEC Form S-8 POS filed by Elevation Oncology Inc.

SEC Form POS AM filed by Elevation Oncology Inc.

SEC Form POS AM filed by Elevation Oncology Inc.

SEC Form 25-NSE filed by Elevation Oncology Inc.

Elevation Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

Amendment: SEC Form SC 14D9/A filed by Elevation Oncology Inc.

Elevation Oncology Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

SEC Form SC 14D9 filed by Elevation Oncology Inc.

SEC Form SC TO-T filed by Elevation Oncology Inc.

CHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 12,560 shares and covered exercise/tax liability with 4,627 shares, increasing direct ownership by 6% to 145,085 units (SEC Form 4)